QID 150562

QID 150562: Spring Cloud Gateway Remote Code Execution Vulnerability (CVE-2022-22947)

Spring Cloud Gateway aims to provide a simple, yet effective way to route to APIs and provide cross cutting concerns to them such as: security, monitoring/metrics, and resiliency.

The installed version of spring cloud gateway application is vulnerable to a code injection attack when the Gateway Actuator endpoint is enabled, exposed and unsecured. A remote attacker could make a maliciously crafted request that could allow arbitrary remote execution on the remote host.

Affected Versions:
Spring Cloud Gateway 3.1.0
Spring Cloud Gateway 3.0.0 to 3.0.6
Older, unsupported versions are also affected

QID Detection Logic:
This QID sends a HTTP POST request containing the payload which triggers a remote code execution on the application. On successful execution, a payload gets executed and detected in the response.

Successful exploitation of this vulnerability could allow a remote attacker to execute arbitrary code on the target system.

  • CVSS V3 rated as Critical - 10 severity.
  • CVSS V2 rated as High - 6.8 severity.
    • Solution
    Customers are advised to Upgrade to Spring Cloud Gateway version 3.0.7, 3.1.1, or later to remediate this vulnerability. For more information regarding this vulnerability please refer VMware Security Advisory
    Vendor References

    CVEs related to QID 150562

    CVE-2022-22947 |
    Software Advisories
    Advisory ID Software Component Link
    VMware URL Logo tanzu.vmware.com/security/cve-2022-22947
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].